LAP3 and neoplasm: The differences in expression of, for example, APO-AI, calreticulin, CK1, endoplasmin, LAP-3, PDI, may affect tumor progression and drug response because these proteins are involved in signaling, cell proliferation, response to hypoxia and oxidative stress.